Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

83%

5 of 6 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A
6(75.0%)
Phase 2
2(25.0%)
8Total
N/A(6)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05937646Not ApplicableCompleted

Improving Providers' Decision-Making and Reducing Information Overload Using Information Visualization in EHRs

Role: collaborator

NCT05495815Not ApplicableWithdrawn

Proper Duration of Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention

Role: collaborator

NCT03715335Not ApplicableCompleted

Adolescent Sexually Transmitted Infection Screening in the Emergency Department

Role: collaborator

NCT04593472Not ApplicableCompleted

SHARE: Sharing Healthcare Wishes in Primary Care

Role: collaborator

NCT06582914Recruiting

Lynch Syndrome Integrative Epidemiology and Genetics

Role: collaborator

NCT05164120Phase 2Completed

Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19

Role: lead

NCT02180243Not ApplicableCompleted

CAM in Veterans With Gulf War Illnesses

Role: collaborator

NCT03984331Not ApplicableCompleted

Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns

Role: collaborator

NCT04874506Phase 2Unknown

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Role: collaborator

All 9 trials loaded